Residency · Memphis, TN
Sponsored by University of Tennessee College of Medicine
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 199 citations · Frederick Boop
Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR): a single-arm, phase 2 study.
The Lancet. Oncology · 2023 · 61 citations · Frederick Boop
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022.
Microbiology spectrum · 2024 · 36 citations · Nicholson Perkins
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Cancer cell · 2021 · 147 citations · Frederick Boop
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature · 2022 · 128 citations · Frederick Boop
Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study.
Neuro-oncology · 2021 · 84 citations · Frederick Boop
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii.
Microbiology spectrum · 2022 · 50 citations · Nicholson Perkins
Enhanced Recovery After Surgery for Pediatric Abdominal Tumor Resections: A Prospective Multi-institution Study.
Journal of pediatric surgery · 2025 · 11 citations · Doralina Angheliescu